SCHEMBL3100625

SCHEMBL3100625

CC(C)OBO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12493612 0.85
Biphenyl SCHEMBL11504602 0.77 PDCD1 (0.46)
SCHEMBL7417411 0.72
SCHEMBL3620607 0.69
SCHEMBL1149313 0.67
SCHEMBL15388940 0.67
SCHEMBL15876806 0.67
SCHEMBL1149385 0.67
Hydrochloric Acid SCHEMBL6843030 0.64
SCHEMBL7357720 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4772751-A EASILY SEPARATED FROM BY-PRODUCTS ALDRICH-BORANES, INC. (US) 1988-09-20 US claimed
US-12091425-B2 Compounds that inhibit MCL-1 protein AMGEN INC. (US) 2024-09-17 US disclosed
US-11760728-B2 Tead inhibitors and uses thereof Ikena Oncology, Inc. (US) 2023-09-19 US disclosed
WO-2023127495-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT キヤノン株式会社 2023-07-06 WO disclosed
US-20230052348-A1 COMPOUNDS THAT INHIBIT MCL-1 PROTEIN AMGEN INC. (US) 2023-02-16 US disclosed
US-11306107-B2 Compounds that inhibit MCL-1 protein AMGEN INC. (US) 2022-04-19 US disclosed
CN-107188898-B Process for preparing thienopyrimidine compounds 霍夫曼-拉罗奇有限公司 2019-12-03 CN disclosed
CN-106573934-B The inhibition of transient receptor potential A1 ion channel 伊莱利利公司 2019-10-11 CN disclosed
CN-109890385-A Crystalline forms of (1R,2R) -2- [4- (3-methyl-1H-pyrazol-5-yl) benzoyl ] -N- (4-oxo-4, 5,6, 7-tetrahydropyrazolo [1,5-a ] pyrazin-3-yl) cyclohexanecarboxamide 阿斯利康(瑞典)有限公司 2019-06-14 CN disclosed
EP-2892904-B1 HIGHLY SELECTIVE C-MET INHIBITORS AS ANTICANCER AGENTS CB THERAPEUTICS INC (KY) 2018-10-17 EP disclosed
US-20150218171-A1 HIGHLY SELECTIVE C-MET INHIBITORS AS ANTICANCER AGENTS APOLLOMICS INC. 2015-08-06 US disclosed
EP-2892904-A1 HIGHLY SELECTIVE C-MET INHIBITORS AS ANTICANCER AGENTS Crown Bioscience Inc. (Taiwan) (CN) 2015-07-15 EP disclosed
US-8957407-B2 Anthracene derivatives, preparation method thereof and organic light emitting diode using the same LG CHEM, LTD. (KR) 2015-02-17 US disclosed
WO-2014032498-A1 HIGHLY SELECTIVE C-MET INHIBITORS AS ANTICANCER AGENTS CROWN BIOSCIENCE INC. (TAICANG) (CN) 2014-03-06 WO disclosed
US-20130178575-A1 CYCLIC OLEFIN COPOLYMER AND CROSSLINKED POLYMER THEREOF MITSUI CHEMICALS, INC. (JP) 2013-07-11 US disclosed
WO-2012154849-A1 POLYMER COMPOSITIONS AND METHODS NOVOMER, INC. (US) 2012-11-15 WO disclosed
US-20100252817-A1 New Anthracene Derivatives, Preparation Method Thereof and Organic Light Emitting Diode Using the Same LG CHEM. LTD. (KR) 2010-10-07 US disclosed
EP-1976814-A1 NEW ANTHRACENE DERIVATIVES, PREPARATION METHOD THEREOF AND ORGANIC LIGHT EMITTING DIODE USING THE SAME LG Chem, Ltd. (KR) 2008-10-08 EP disclosed
WO-2007086695-A1 NEW ANTHRACENE DERIVATIVES, PREPARATION METHOD THEREOF AND ORGANIC LIGHT EMITTING DIODE USING THE SAME LG CHEM. LTD. (KR) 2007-08-02 WO disclosed
WO-2006065001-A1 BIMETALLIC ZINC COMPLEX AND PROCESS OF PRODUCING POLYCARBONATE USING THE SAME AS POLYMERIZATION CATALYST LG CHEM. LTD. (KR) 2006-06-22 WO disclosed